Compliance review: Sun Pharma’s Halol plant gets 8 USFDA...

Compliance review: Sun Pharma’s Halol plant gets 8 USFDA observations; company vows remedial steps after inspection

Posted

Sun Pharmaceutical Industries faces scrutiny. The USFDA issued a Form 483. This follows an inspection of its Halol manufacturing plant in Gujarat. The inspection occurred between June 2 and June 13, 2025. Eight observations were noted regarding Good Manufacturing Practices. Sun Pharma is expected to respond. They will submit a remediation plan to address the concerns.

Read Full Article

Please log in to like, share and comment!

Business

From cars to couture: Kering appoints Renault’s Luca De Meo to lead Gucci; French high-fashion brand hopes for revival

Kering has appointed Luca de Meo, renowned for revitalizing Renault, as its new CEO to revive...

Von 0 2

Entertainment

Aruna reveals why she was never close to cousin Bindu

Aruna Irani, one of Indian cinema’s most prolific actresses with over 500 films to her...

Von 0 6

International

World Bank lifts ban on nuclear energy financing

The World Bank is set to re-enter the nuclear energy sector after decades, announced President...

Von 0 6

International

Schengen-style GCC Unified Tourist Visa approved, to be rolled out soon

The GCC has approved a unified tourist visa allowing travel across all six member states, UAE,...

Von 0 6

Entertainment

Aruna was reluctant to do nude scene with Rishi in Bobby

Rishi Kapoor’s 'Bobby' co-star Aruna Irani recently opened up about one of the late...

Von 0 13